Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor.

Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitor.

<h4>Background</h4>Some clinical studies have demonstrated that the proton pump inhibitor (PPI) could decrease clopidogrel platelet response and increase major adverse cardiovascular events (MACE) in white or black subjects. However, that remains to be determined in Chinese patients. In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jian-Jun Zou, Shao-Liang Chen, Jie Tan, Ling Lin, Ying-Ying Zhao, Hai-Mei Xu, Song Lin, Juan Zhang, Hong-Wei Fan, Hong-Guang Xie
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/cc4d41f16a17445982952b04cb94cf8e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares